What is 20BY25?
20BY25 is a public education campaign that increases awareness about the importance of cancer clinical trials. The goal is to enroll 20% of all individuals with newly diagnosed and relapsed cancers onto clinical trials by the year 2025.
Overall Goal
Ensure that the people of Hawaiʻi receive the highest quality of cancer care
Initiatives
Achieve enrollment to cancer clinical trials of 20 percent of all individuals with newly diagnosed and relapsed cancers each year by 2025. We will accomplish by:
- Providing community education about cancer clinical trials,
- Engaging and training of oncology providers, and
- Encouraging enrollment to cancer clinical trials
Long Term Goal
Hawaiʻi will be the ONLY state in the US to achieve this high proportion of enrollment to clinical trials statewide.
- There are ∼6500 new cancer cases each year in Hawaiʻi
- The goal is to enroll 1300 patients per year onto a cancer clinical trial
- At least one-fourth of these enrollments should be to treatment-based trials. Others may be to cancer prevention, supportive care, diagnostic and cancer healthcare delivery trials.
The University of Hawaiʻi Cancer Center, which already provides a clinical trial infrastructure for over 2/3 of cancer patients in the State, is uniquely positioned to lead this initiative.
